Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Engelman
Professor Mark Engelman on Deepfake Technology, Legal Challenges & Global Image Rights
AI The EU And US - The Deep Fake Deepfake is now used to create a range of digital materials from child abuse video clips to faking the voice over and images of well-known personalities in the entertainment industry… One of the world’s all-time impostors was Arthur Orton, aka Thomas Castro. He was a butcher from Wagga Wagga, Australia and having seen the Dowager Lady Tichborne’s... Access Exclusive Legal Era Stories, Editorial Insights, and Expert Opinion. Already a subscriber?
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
AI the EU and US – Part 2-The Deep Fake | BARRISTER MAGAZINE
By Professor Mark Engelman, Barrister, 4-5 Gray’s Inn Square One of the world’s all-time impostors was Arthur Orton, aka Thomas Castro. He was a butcher from Wagga Wagga, Australia and having seen the Dowager Lady Tichborne’s newspaper article requesting news of her son who had left Great Britain in 1823 assail The Bella, which had floundered and was presumed lost responded by claiming to be her estranged son.
New Research Points to the Gut As Key for Depression Treatment
They say the way to a person’s heart is through the stomach. The same could be said about a person’s brain. With all that we’re now learning about the gut-brain axis, it is becoming clear that mood, cognitive function, sleep cycles, and many other aspects of our psychological health are directly influenced by factors originating in the gastrointestinal tract.
The Way to Your Mental Health is Through Your Stomach
They say the way to a person’s heart is through their stomach. Well, the same can be said for one’s mental health! It’s a little-known fact that serotonin—the hormone that controls moods—is created in the gut. Without a properly functioning gut, which needs a healthy diet to operate, the resulting imbalance in those hormones may disrupt the production of serotonin leading to depression and other poor mental health outcomes. What is Serotonin?
Processed Foods & Energy Drinks: A Public Health Emergency
Highly processed foods and energy drinks do more harm than good—and Americans have a huge appetite for them. That’s bad news for the future health of the country. According to a new analysis of data from nearly 41,000 US adults, consumption of ultra-processed foods rose markedly from 2001 to 2018, accounting for nearly 60% of the total calories in the typical US adult’s diet in 2018.
Preparing Patients for This Winter’s “Twindemic”
As we head into the peak months for the flu, we as health care providers need to be especially vigilant about the integrity of our patients’ immune systems. Paired with COVID-19, this year’s flu season carries the serious risk of compromising their future immune response. A key step in preventing these complications lies in helping our patients understand the strengths and weaknesses of their immune systems.
Helping Families Bolster Immunity As Kids Return to School
As parents and children head into a new school year in which in-person learning will once again be the norm, we as health care practitioners need to prepare ourselves for advising parents on how to protect themselves and their children. The Delta variant and other variants of the SARS-CoV-2 virus are grabbing headlines these days, but we also need to consider the fact that older pathogens like Respiratory Syncytial Virus (RSV) are still out there. And flu season has begun early this year.
Immune System “Fingerprinting” Gives Insight on Autoimmune Conditions
A recent study published in the journal Arthritis and Rheumatology, shows that the prevalence of antinuclear antibodies (ANA)– the most common biomarker of autoimmunity–has increased considerably in the United States in recent years. Researcher Gregg E. Dinse and colleagues at Social & Scientific Systems, Durham, NC, examined the prevalence of ANA positivity in human subjects from three distinct time periods between 1988 and 2012. In total, they had data from 14,211 individuals.
Bolstering Mucosal Barriers is Key to Boosting Immunity
The COVID-19 pandemic, along with the onset of flu season, have a lot of people thinking about their immune systems, and seeking ways to improve resilience to viruses and other types of infection. The best way to help patients strengthen their immunity is to work with them to optimize gut health and strengthen epithelial barriers.
Why things could get ugly over COVID-19 patents
Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers. In a time of crisis, access to appropriate pharmaceuticals is of paramount importance. At present there are six UK centres attempting to find an antiviral treatment for the COVID-19 virus. There are many more other drug interventions being sought around the world to stop the rampage of the virus. The World Health Organization (WHO) lists at least 60 such projects.
Is the door closing on the Unified Patent?
To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription. Please login or subscribe in order to continue reading. Claim a week's trial subscription by signing up for free today and receive our daily pharma and biotech news bulletin free of charge, forever.
An IP lawyer's take on the Eli Lilly v Actavis judgement
To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription. Please login or subscribe in order to continue reading. Claim a week's trial subscription by signing up for free today and receive our daily pharma and biotech news bulletin free of charge, forever.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack